Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment

Therapeutic advance in progressive multiple sclerosis (MS) has been very slow. Based on the transformative role magnetic resonance imaging (MRI) contrast-enhancing lesions had on drug development for relapsing-remitting MS, we consider the lack of sensitive outcomes to be the greatest barrier for de...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosa, Peter, Ghazali, Danish, Tanigawa, Makoto, Barbour, Chris, Cortese, Irene, Kelley, William, Snyder, Blake, Ohayon, Joan, Fenton, Kaylan, Lehky, Tanya, Wu, Tianxia, Greenwood, Mark, Nair, Govind, Bielekova, Bibiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983704/
https://www.ncbi.nlm.nih.gov/pubmed/27574516
http://dx.doi.org/10.3389/fneur.2016.00131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983704/
https://www.ncbi.nlm.nih.gov/pubmed/27574516
http://dx.doi.org/10.3389/fneur.2016.00131

Ejemplares similares